Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SANDVED FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   2.0% 1.4% 1.9% 1.7% 3.1% 1.5% 19.1% 19.1%   Credit score (0-100)   70 79 71 72 56 75 7 7   Credit rating   A A A A BBB A B B   Credit limit (kDKK)   0.1 6.9 0.3 0.9 0.0 3.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   404 594 322 381 228 459 0.0 0.0   EBITDA   100 299 24.3 84.1 -30.1 190 0.0 0.0   EBIT   100 299 24.3 84.1 -30.1 190 0.0 0.0   Pre-tax profit (PTP)   99.1 297.7 22.9 79.6 -39.0 178.1 0.0 0.0   Net earnings   75.8 229.0 17.2 61.7 -30.4 138.3 0.0 0.0   Pre-tax profit without non-rec. items   99.1 298 22.9 79.6 -39.0 178 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   155 123 92.2 61.0 43.6 40.1 0.0 0.0   Shareholders equity total   339 539 556 568 423 461 29.5 29.5   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   423 659 622 654 576 772 29.5 29.5   Net Debt   -139 -386 -412 -475 -401 -623 -29.5 -29.5     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   404 594 322 381 228 459 0.0 0.0   Gross profit growth   11.6% 47.1% -45.9% 18.4% -40.0% 100.9% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   423 659 622 654 576 772 29 29   Balance sheet change%   17.7% 55.8% -5.7% 5.2% -12.0% 34.1% -96.2% 0.0%   Added value   100.4 298.7 24.3 84.1 -30.1 189.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -31 -31 -31 -31 -17 -3 -40 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.8% 50.3% 7.5% 22.1% -13.2% 41.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   25.7% 55.2% 3.8% 13.2% -4.9% 28.1% 0.0% 0.0%   ROI %   32.5% 66.9% 4.4% 14.9% -6.1% 42.5% 0.0% 0.0%   ROE %   25.1% 52.1% 3.1% 11.0% -6.1% 31.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   80.3% 81.8% 89.5% 86.8% 73.5% 59.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -138.5% -129.3% -1,695.4% -564.2% 1,333.4% -328.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.0 4.4 8.0 6.5 3.2 2.3 0.0 0.0   Current Ratio   3.0 4.4 8.0 6.5 3.2 2.3 0.0 0.0   Cash and cash equivalent   139.0 386.3 411.5 474.7 400.8 622.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   148.9 379.0 425.3 465.1 336.1 385.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 190 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 190 0 0   EBIT / employee   0 0 0 0 0 190 0 0   Net earnings / employee   0 0 0 0 0 138 0 0